Linezolid

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

利奈唑胺是一种合成抗生素，是恶唑烷酮类中的第一种抗生素。

Linezolid is a synthetic antibiotic, the first of the oxazolidinone class, used for the treatment of infections caused by multi-resistant bacteria including streptococcus and methicillin-resistant Staphylococcus aureus (MRSA). The drug works by inhibiting the initiation of bacterial protein synthesis. (In Vitro):Linezolid (PNU-100766) prevents the synthesis of bacterial protein via binding to rRNA on both the 30S and 50S ribosomal subunits.

Linezolid (PNU-100766) prevents the synthesis of bacterial protein via binding to rRNA on both the 30S and 50S ribosomal subunits.

——

PNU 100766

Metabolic Enzyme/Protease

MAO

AOA| AOB

Infection

——

165800-03-3

337.35

C16H20FN3O4

>98% (HPLC)

Ethanol: 8 mg/mL (23.71 mM); DMSO: 67 mg/mL (198.6 mM)

CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)N3CCOCC3)F

N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide

(-20℃)

With Ice Pack

≥ 2 years